XORTX to Present at LD Micro Invitational 2022

CALGARY, Alberta, June 08, 2022 -- XORTX Therapeutics Inc. , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased... | June 8, 2022

Related Keywords

Canada ,Canadian ,Nick Rigopulos ,Allen Davidoff ,Exchange Commission ,Therapeutics Inc ,Seasons Hotel Westlake Village ,Venture Exchange ,Nasdaq ,Globenewswire Inc ,Autosomal Dominant Polycystic Kidney Disease ,Annual Information Form ,Management Discussion ,Xortx Therapeutics Inc Stock Exchange ,News ,Information ,Press Release ,Pune ,022 ,Xortx ,Herapeutics ,Gate ,Stage ,Linical ,Harmaceutical ,Company ,Ocused ,N ,Developing ,Nnovative ,Therapies ,O ,Treat ,Progressive ,Kidney ,S Xrtx Ca98420q2071 ,